Emdeon Inc., through its subsidiaries, provides revenue and payment cycle management and clinical information exchange solutions that connect payers, providers, and patients in the United States healthcare system. Its product and service offerings integrate and automate business and administrative functions for healthcare payers and healthcare providers throughout the patient encounter. The company operates in three segments: Payer Services, Provider Services, and Pharmacy Services. The Payer Services segment provides payment cycle solutions that simplify the administration of healthcare related to insurance eligibility and benefit verification, claims management, payment integrity, and paym...
3055 Lebanon Pike
Nashville, TN 37214
Founded in 2006
Emdeon Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Reports Impairment Charges for the Fourth Quarter of 2014
Mar 16 15
Emdeon Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported revenue of $353.4 million, an increase of 10.4%, compared to $320.1 million for the same period in 2013. This increase in revenue was primarily due to business growth. Net loss for the fourth quarter of 2014 was $0.3 million compared to $16.5 million for the same period in 2013. This improvement in net loss was primarily due to business growth and the absence of a charge related to cancelling a product development project in the prior year period. Non-GAAP Adjusted EBITDA increased 18.8% to $101.7 million, or 28.8% of revenue, from Non-GAAP Adjusted EBITDA of $85.5 million, or 26.7% of revenue, for the comparable period in 2013. This increase in Adjusted EBITDA and as a percentage of revenue compared to the same period in 2013 is primarily due to business growth and productivity improvements throughout the business. Operating income was $36.279 million against $6.888 million a year ago. Income before income tax provision was $1.530 million against loss before income tax provision of $26.735 million a year ago. EBITDA was $86.296 million against $55.940 million a year ago.
For the year, the company reported revenue of $1,350.4 million compared to $1,242.6 million for 2013, an increase of 8.7%. This increase in revenue was primarily due to business growth, accelerated by the impact of healthcare utilization, new solutions and acquisitions. Net loss for 2014 was $75.9 million compared to $74.5 million in 2013. Full year 2014 Non-GAAP Adjusted EBITDA increased 12.5% to $364.3 million, or 27.0% of revenue, from Non-GAAP Adjusted EBITDA of $324.0 million, or 26.1% of revenue, for the comparable period in 2013. This increase was primarily due to the impact of business growth in higher margin businesses and productivity improvements. Operating income was $26.449 million against $60.984 million a year ago. Loss before income tax provision was $117.719 million against $111.143 million a year ago. Net cash provided by operating activities was $205.671 million against $150.400 million a year ago. Purchases of property and equipment were $55.926 million against $71.086 million a year ago. EBITDA was $218.328 million against $225.865 million a year ago.
For the fourth quarter of 2014, the company reported impairment of long-lived assets of $479,000 against $8,732,000 a year ago.
Merge Healthcare Teams Up with Emdeon for Technology Integration
Feb 10 15
Merge Healthcare has partnered with Emdeon, to combine their technologies. As agreed, the Emdeon Clinical Exchange will be equipped with capabilities that allow customers to send electronic referrals and receive radiology reports from Merge iConnect Network users. Hospitals and imaging centers on the Merge iConnect Network will be able to electronically receive and transmit imaging orders and results to Emdeon's network of providers.
Emdeon Inc. Announces Proposed Increase in Term Loan
Dec 2 14
Emdeon Inc. announced its intention to increase its outstanding term loan borrowings by up to $160 million for general corporate purposes, including acquisitions. Emdeon anticipates the transaction will be completed in December 2014. However, there can be no assurance that Emdeon will be able to complete this transaction, which remains subject to market and other customary conditions.